MEDI 4736 (D419NC00001): A Phase 1 Study of Durvalumab and IPH2201 in Adult Subjects with Select Advanced Solid Tumors

March 14, 2017
https://clinicaltrials.gov/ct2/show/NCT02671435
Solid Tumors
Principal Investigator: Ding Wang, MD
Advanced Solid Tumors
Accepting Participants
(313)916-1784